| Total no. women | HPV positive, n (%) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) |
---|---|---|---|---|
Age groups | Â | Â | Â | Â |
16-24 | 136 (4.5) | 7 (5.1) | 1 | 1 |
25-34 | 756 (25.1) | 44 (5.8) | 1.14 (0.50-2.58) | 1.20 (0.53-2.73) |
35-44 | 919 (30.6) | 51 (5.5) | 1.08 (0.48-2.44) | 1.15 (0.51-2.59) |
45-54 | 835 (27.8) | 54 (6.5) | 1.27 (0.57-2.86) | 1.36 (0.60-3.07) |
≥55 | 362 (12.0) | 26 (7.2) | 1.43 (0.60-3.37) | 1.49 (0.63-3.54) |
Cytology results | Â | Â | Â | Â |
Normal cytology | 2959 (98.4) | 173 (5.8) | 1 | 1 |
Abnormal cytology | 49 (1.6) | 9 (18.4) | 3.62 (1.73-7.59)* | 3.68 (1.75-7.75) |
Clinical findings | Â | Â | Â | Â |
Routine smear test | 2401 (79.8) | 142 (5.9) | 1 | 1 |
Symptomatic results≠| 607 (20.2) | 40 (6.6) | 1.12 (0.78-1.61) | 1.15 (0.80-1.65) |
Nationality | Â | Â | Â | Â |
Qatari | 1404 (46.7) | 87 (6.2) | 1 | 1 |
Non-Qatari | 1604 (53.3) | 95 (5.9) | 0.95 (0.71-1.29) | 1.00 (0.73-1.36) |
Nationality | Â | Â | Â | Â |
Qatari | 1404 (46.7) | 87 (6.2) | 1 | -- |
Egyptian | 465 (15.5) | 26 (5.6) | 0.90 (0.57-1.41) | Â |
Arabian peninsula$ | 310 (10.3) | 14 (4.5) | 0.72 (0.40-1.28) | Â |
Fertile Crescent£ | 566 (18.8) | 37 (6.5) | 1.06 (0.71-1.58) |  |
North Africa# | 95 (3.2) | 7 (7.4) | 1.20 (0.54-2.68) | Â |
East Africa^ | 168 (5.6) | 11 (6.5) | 1.06 (0.55-2.03) | Â |